Skip to main content

Table 2 Estimateda 10 year risk of developing a cardiovascular disease (%)

From: Pharmacoeconomics of PCSK9 inhibitors in 103 hypercholesterolemic patients referred for diagnosis and treatment to a cholesterol treatment center

 

Mean ± SD %

Percentiles

10th

25th

50th

75th

90th

All 103 patients

14.1 ± 12.3

2.0

5.0

11.3

20.5

27.4

61 patients had CVD event pre study

15.9 ± 11.7

3.5

7.2

13.1

21.4

27.4

Years since 1st CVD event in the 61 patients

10.3 ± 8.9

1.4

2.9

8.2

16.3

19.5

42 patients had no CVD

11.5 ± 12.8

1.8

3.4

6.8

18.0

21.6

  1. aEstimated using the ACC/AHA calculator
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X